CN104740559A - Traditional Chinese medicine composition for diminishing inflammation and benefiting gallbladder - Google Patents
Traditional Chinese medicine composition for diminishing inflammation and benefiting gallbladder Download PDFInfo
- Publication number
- CN104740559A CN104740559A CN201410609337.2A CN201410609337A CN104740559A CN 104740559 A CN104740559 A CN 104740559A CN 201410609337 A CN201410609337 A CN 201410609337A CN 104740559 A CN104740559 A CN 104740559A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- chinese medicine
- medicine composition
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for diminishing inflammation and benefiting gallbladder. The traditional Chinese medicine composition for diminishing inflammation and benefiting gallbladder comprises the following raw materials in parts by weight: 29-31 parts of poria cocos, 9-11 parts of white atractylodes rhizome, 14-16 parts of angelica sinensis, 14-16 parts of picrasma quassioides, 9-11 parts of radix paeoniae alba, 14-16 parts of dandelion, 14-16 parts of radix bupleuri, 9-11 parts of pogonatum microstomum, 4-6 parts of corydalis curviflora, 9-11 parts of ginger and 14-16 parts of liquorice. The traditional Chinese medicine composition for diminishing inflammation and benefiting gallbladder disclosed by the invention aims at the etiology and pathogenesis of cholecystitis, is based on the traditional Chinese medicine therapy, takes poria cocos as a monarch medicine, takes white atractylodes rhizome, angelica sinensis, picrasma quassioides and radix paeoniae alba as minister medicines, takes dandelion, radix bupleuri, pogonatum microstomum, corydalis curviflora and ginger as adjuvant medicines, takes liquorice as a guide medicine, fundamentally removes the etiology while improving the symptoms of patients, and has a total effective rate of 90%.
Description
Technical field
The present invention relates to technical field of Chinese medicines, particularly relate to a kind of Chinese medicine composition of anti-inflammatory and choleretic.
Background technology
Cholecystitis is more common disease, and sickness rate is higher.According to its clinical manifestation and clinical process, can be divided into again acute with chronic two types, normal and cholelithiasis merges and exists.Upper right abdomen severe pain or angor, mostly be calculus or parasite incarceration and block acute cholecystitis caused by neck of gallbladder, pain often breaks out, and very acutely, or presents angor sample.During cystic duct non-obstructivity acute cholecystitis, right Upper abdominal pain is general inviolent, and mostly be persistence distending pain, along with the progress of gallbladder inflammation, pain also can increase the weight of, and pain presents radioactivity, and modal radiation position is the place such as right shoulder and right inferior angle of scapula.
The traditional Chinese medical science thinks that gallbladder is " fu-viscera with clear juice ", invests liver under being positioned at right flank, and with liver phase the exterior and the interior, defeated bile and do not pass digesting and absorbing the essence of foodstuff, functionally to fall behavior suitable with logical.Any factor, when having influence on " in clear " and " lead to and fall row " of gallbladder, can be fallen ill.Following factors can cause " in clear " of gallbladder and " lead to and fall row ": (1) disorder of emotion: liver controlling conveyance and dispersion, property happiness bar reach, dredge promoting the circulation of QI machine, the secretion of bile, conveying, storage, excretion are normally carried out, to help taste to receive digesting and absorbing the essence of foodstuff, excessive anxiety and rage, feelings will are smooth, cause depression of liver-QI, catharsis is not normal, thus make that bileization is raw, conveying, abevacuation and causing a disease; (2) eating and drinking without temperance: hungry full variable, surfeit delicious food savoury, pungent pure wine etc., cause transformation and transportation of the spleen and stomach not normal, endogenous damp formation, hinders mechanism of qi, strongly fragrant and heat-transformation, hot and suffocatingly accumulates steaming mutually with turbid damp, and gallbladder internal organs loses and falls in leading to and fall ill; (3) ascarid disturbs: ascarid disturbs, make QI depression of the liver and gallbladder, catharsis is neglected one's duty, and bile excretion is smooth, heat-transformation for a long time, damp and hotly accumulates steaming, forms cholelithiasis; (4) exopathogen invasion and attack: cold temperature is uncomfortable, being invaded by exogenous pathogen, few positive disorder of QI movement, gallbladder internal organs loses and falls in logical.
The pathogenesis of primary disease is generally initial with QI depression of the liver and gallbladder.Various paathogenic factor above, can cause depression of liver-QI, courage is obstructed, abdominal and hypochondriac pain; Perverse and unreasonable manner violates stomach, therefore nausea and vomiting; Transporting and transforming function of the spleen and stomach is not normal, retention of damp-heat in the interior, then become dampness-heat in the liver and gallbladder, thus heating or alternate attack of chill and fever, bitter taste.Damp and hot friendship is steamed, and forces bile excessive, then skin, white of the eye jaundice.Abdominal and hypochondriac pain, heating are the primary symptoms of cholelithiasis, and developing into certain phase can occur jaundice.If accumulation of heat does not fall apart, then putrefaction of blood and muscle, wine forms pus.Pyretic toxicity fire-transformation, invade nutrient blood or in disturb gods, very then " exhaustion of YIN " ", YANG-depletion ".
Summary of the invention
The technical problem that basic background technology exists, the present invention proposes a kind of Chinese medicine composition of anti-inflammatory and choleretic, for the etiology and pathogenesis of cholecystitis, according to the principle of tcm syndrome differentiation and treatment, take Poria as monarch drug, with the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis, Ramulus Et Folium Picrasmae and the Radix Paeoniae Alba for ministerial drug, with Herba Taraxaci, Radix Bupleuri, Pogonatum microstomum (schwaegr) Brid, Corydalis curviflora Maxim and Rhizoma Zingiberis Recens for adjuvant drug, with Radix Glycyrrhizae for making medicine, while improving patients symptomatic, fundamentally remove the cause of disease, total effective rate can reach 90%.
The Chinese medicine composition of a kind of anti-inflammatory and choleretic that the present invention proposes, its raw material comprises by weight: Poria 29-31 part, Rhizoma Atractylodis Macrocephalae 9-11 part, Radix Angelicae Sinensis 14-16 part, Ramulus Et Folium Picrasmae 14-16 part, Radix Paeoniae Alba 9-11 part, Herba Taraxaci 14-16 part, Radix Bupleuri 14-16 part, Pogonatum microstomum (schwaegr) Brid 9-11 part, Corydalis curviflora Maxim 4-6 part, Rhizoma Zingiberis Recens 9-11 part, Radix Glycyrrhizae 14-16 part.
Poria is the dry sclerotia of On Polyporaceae Poria.Sweet in the mouth, light, property is put down.GUIXIN, lung, spleen, kidney channel.There is eliminating dampness and diuresis, invigorating the spleen and regulating the stomach, effect of mind tranquilizing and the heart calming.Cure mainly dysuria, edema distension, phlegm retention cough with dyspnea, vomiting, insufficiency of the spleen lack of appetite, has loose bowels, palpitation and restlessness, insomnia forgetfulness, seminal emission nebulousurine.
The Rhizoma Atractylodis Macrocephalae is the dry rhizome of the feverfew Rhizoma Atractylodis Macrocephalae.Bitter in the mouth, sweet, warm in nature.Return spleen, stomach warp.There is invigorating the spleen and benefiting QI, dampness diuretic, hidroschesis, antiabortive function.For insufficiency of the spleen lack of appetite, abdominal distention is had loose bowels, phlegm retention vertigo and palpitation, edema, spontaneous perspiration, frequent fetal movement.
Radix Angelicae Sinensis, acrid in the mouth, sweet, warm in nature, GUIXIN warp, spleen channel, Liver Channel.Energy benefiting blood and regulating blood circulation, menstruction regulating and pain relieving, moisturizes laxation.Cure mainly menoxenia, amenorrhea is suffered from abdominal pain, and lump in the abdomen knot is poly-, metrorrhagia; Headache due to deficiency of blood, dizzy, flaccidity syndrome and arthralgia syndrome; Dryness of the intestine dyschezia is heavy after bloody dysentery; Carbuncle skin ulcer is stolen, injury from falling down.
Ramulus Et Folium Picrasmae, the dry branch of quassia Ramulus Et Folium Picrasmae and leaf.Summer, Qiu Erji gather, removing impurity, and branch is cleaned, and runs through, and section, dries; Foliar spray drenches clear water, slightly moistens, shredding, dries.Bitter in the mouth, cold in nature, return lung meridian, large intestine channel.There is antibacterial quench, effect of damp eliminating removing toxic substances.For flu, acute tonsillitis, enteritis, eczema, venom.
The Radix Paeoniae Alba is the root of ranunculaceae plant Radix Paeoniae removing crust.Bitter in the mouth, acid, cold nature.Enter Liver Channel.There is the yin fluid astringing that nourishes blood, easing the affected liver to relieve pain, effect of suppressing the hyperactive liver sun.For menoxenia, abdominal pain during menstruation, metrorrhagia, spontaneous perspiration, night sweat, and hypochondriac pain, the stomachache caused by disharmony in liver-QI, and the disease such as contracture of the limbs pain, regulating liver-QI yang hyperactivity contain caused by headache, dizzy.
Herba Taraxaci, Dandelion Compositae herbaceos perennial.Sweet in the mouth, hardship, cold in nature, return stomach, Liver Channel.There is heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, effect of inducing diuresis for treating stranguria syndrome.For furuncle swelling toxin, acute mastitis, scrofula, conjunctival congestion, pharyngalgia, lung abscess, acute appendicitis, jaundice due to damp-heat, the puckery pain of pyretic stranguria.Modern pharmacology confirms, containing multiple health-nutrition compositions such as taraxol, taraxacin, choline, organic acid, inulin in Herba Taraxaci plant, has the effects such as diuresis, cathartic, jaundice eliminating subcutaneous ulcer, function of gallbladder promoting.
Radix Bupleuri is the dry root of umbelliferae bupleurum or Radix Bupeuri Scorzonerfolii..Bitter in the mouth, cold nature.Return liver, gallbladder meridian.There is reconciling superficies and interior, soothing the liver, effect of yang invigorating.For cold, fever, alternate attack of chill and fever, distending pain in the chest and hypochondrium, menoxenia, uterine prolapse, proctoptosis.
Pogonatum microstomum (schwaegr) Brid is the herb of pigeon-wheat section plant Pogonatum microstomum (schwaegr) Brid.Acrid in the mouth, cool in nature, return gallbladder meridian, Liver Channel.There is 'Shugan Lidan '; Effect of calculus pain relieving.Cure mainly gallbladder JISHI etc.
Corydalis curviflora Maxim is the herb of dicotyledon medicine Papaveraceae Genus Corydalis.Bitter in the mouth, cold in nature, enter lung, liver, gallbladder three warp.There is effect of heat-clearing and toxic substances removing, cooling blood for hemostasis, clearing heat secreting bile.Cure mainly the cards such as heating that fever caused by exogenous pathogenic factors causes, aversion to cold, thirsty, the few tongue of oliguria, red tongue.That controls that bleeding due to blood-heat causes goes out blood disorder and married woman's menorrhagia, jaundice due to damp-heat.
Rhizoma Zingiberis Recens is the fresh rhizome of ginger Rhizoma Zingiberis Recens.Autumn, season in winter two excavate, and removing fibrous root and silt, medicinal is good with old ginger.Acrid in the mouth, slightly warm in nature, return lung, spleen, stomach warp.There is the cold expelling that induces sweat, warming middle-JIAO to arrest vomiting, preventing phlegm from forming and stopping coughing.For anemofrigid cold, gastrofrigid vomiting, cold-phlegm is coughed.
Radix Glycyrrhizae, property is put down, and sweet in the mouth, returns stomach warp, lung meridian, spleen channel.There is heat-clearing and toxic substances removing, nourishing the lung to arrest cough, effect of coordinating the actions of various ingredients in a prescription.Cure mainly laryngopharynx swelling and pain, cough, weakness of the spleen and stomach, taste-blindness rate, hepatitis, hysteria, carbuncle furuncle and phyma poison, medicine and alimentary toxicosis.
Preferably, the weight ratio of the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis, Ramulus Et Folium Picrasmae and the Radix Paeoniae Alba is 9.7-10.8:14.2-15.6:14.4-15.7:9.5-10.1.
Preferably, its raw material comprises by weight: Poria 29.3-30.5 part, Rhizoma Atractylodis Macrocephalae 9.7-10.8 part, Radix Angelicae Sinensis 14.2-15.6 part, Ramulus Et Folium Picrasmae 14.4-15.7 part, Radix Paeoniae Alba 9.5-10.1 part, Herba Taraxaci 14.1-15.2 part, Radix Bupleuri 14.6-15.3 part, Pogonatum microstomum (schwaegr) Brid 9.9-10.2 part, Corydalis curviflora Maxim 4.7-5.2 part, Rhizoma Zingiberis Recens 9.2-10.8 part, Radix Glycyrrhizae 14.5-15.5 part.
Preferably, its raw material comprises by weight: 30 parts, Poria, the Rhizoma Atractylodis Macrocephalae 10 parts, Radix Angelicae Sinensis 15 parts, Ramulus Et Folium Picrasmae 15 parts, the Radix Paeoniae Alba 10 parts, Herba Taraxaci 15 parts, Radix Bupleuri 15 parts, Pogonatum microstomum (schwaegr) Brid 10 parts, Corydalis curviflora Maxim 5 parts, 10 parts, Rhizoma Zingiberis Recens, 15 parts, Radix Glycyrrhizae.
The present invention is directed to the etiology and pathogenesis of cholecystitis, take Poria as monarch drug, eliminating dampness and diuresis, invigorating the spleen and regulating the stomach, mind tranquilizing and the heart calming; With the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis, Ramulus Et Folium Picrasmae and the Radix Paeoniae Alba for ministerial drug, auxiliary monarch drug, invigorating the spleen and benefiting QI, dampness diuretic, menstruction regulating and pain relieving, antibacterial and detoxicating, nourish blood yin fluid astringing, easing the affected liver to relieve pain, suppressing the hyperactive liver sun; With Herba Taraxaci, Radix Bupleuri, Pogonatum microstomum (schwaegr) Brid, Corydalis curviflora Maxim and Rhizoma Zingiberis Recens for adjuvant drug, assist monarch drug and ministerial drug on the one hand, further heat-clearing and toxic substances removing, dispersing swelling and dissipating binds, 'Shugan Lidan ', calculus pain relieving, relaxes the excessively strong pathogenic fire reducing of monarch drug and ministerial drug, the performance of dampness on the other hand, and the cold expelling that can induce sweat, warming middle-JIAO to arrest vomiting; Again with Radix Glycyrrhizae for making medicine, coordinating the actions of various ingredients in a prescription, reduce toxicity, make the present invention while improving patients symptomatic, fundamentally remove the cause of disease, total effective rate can reach 90%.
Detailed description of the invention
Below, by specific embodiment, technical scheme of the present invention is described in detail.
Embodiment 1
The Chinese medicine composition of a kind of anti-inflammatory and choleretic that the present invention proposes, its raw material comprises by weight: 31 parts, Poria, the Rhizoma Atractylodis Macrocephalae 9 parts, Radix Angelicae Sinensis 16 parts, Ramulus Et Folium Picrasmae 14 parts, the Radix Paeoniae Alba 11 parts, Herba Taraxaci 14 parts, Radix Bupleuri 16 parts, Pogonatum microstomum (schwaegr) Brid 9 parts, Corydalis curviflora Maxim 6 parts, 9 parts, Rhizoma Zingiberis Recens, 16 parts, Radix Glycyrrhizae.
Embodiment 2
The Chinese medicine composition of a kind of anti-inflammatory and choleretic that the present invention proposes, its raw material comprises by weight: 29.3 parts, Poria, the Rhizoma Atractylodis Macrocephalae 10.8 parts, Radix Angelicae Sinensis 14.2 parts, Ramulus Et Folium Picrasmae 15.7 parts, the Radix Paeoniae Alba 9.5 parts, Herba Taraxaci 15.2 parts, Radix Bupleuri 14.6 parts, Pogonatum microstomum (schwaegr) Brid 10.2 parts, Corydalis curviflora Maxim 4.7 parts, 10.8 parts, Rhizoma Zingiberis Recens, 14.5 parts, Radix Glycyrrhizae.
Embodiment 3
The Chinese medicine composition of a kind of anti-inflammatory and choleretic that the present invention proposes, its raw material comprises by weight: 30 parts, Poria, the Rhizoma Atractylodis Macrocephalae 10 parts, Radix Angelicae Sinensis 15 parts, Ramulus Et Folium Picrasmae 15 parts, the Radix Paeoniae Alba 10 parts, Herba Taraxaci 15 parts, Radix Bupleuri 15 parts, Pogonatum microstomum (schwaegr) Brid 10 parts, Corydalis curviflora Maxim 5 parts, 10 parts, Rhizoma Zingiberis Recens, 15 parts, Radix Glycyrrhizae.
Embodiment 4
The Chinese medicine composition of a kind of anti-inflammatory and choleretic that the present invention proposes, its raw material comprises by weight: 29 parts, Poria, the Rhizoma Atractylodis Macrocephalae 11 parts, Radix Angelicae Sinensis 14 parts, Ramulus Et Folium Picrasmae 16 parts, the Radix Paeoniae Alba 9 parts, Herba Taraxaci 16 parts, Radix Bupleuri 14 parts, Pogonatum microstomum (schwaegr) Brid 11 parts, Corydalis curviflora Maxim 4 parts, 11 parts, Rhizoma Zingiberis Recens, 14 parts, Radix Glycyrrhizae.
Embodiment 5
The Chinese medicine composition of a kind of anti-inflammatory and choleretic that the present invention proposes, its raw material comprises by weight: 30.5 parts, Poria, the Rhizoma Atractylodis Macrocephalae 9.7 parts, Radix Angelicae Sinensis 15.6 parts, Ramulus Et Folium Picrasmae 14.4 parts, the Radix Paeoniae Alba 10.1 parts, Herba Taraxaci 14.1 parts, Radix Bupleuri 15.3 parts, Pogonatum microstomum (schwaegr) Brid 9.9 parts, Corydalis curviflora Maxim 5.2 parts, 9.2 parts, Rhizoma Zingiberis Recens, 15.5 parts, Radix Glycyrrhizae.
Select embodiment 3 to prepare medicament, three times on the one, each 15g, surrounding is a course for the treatment of.Random selecting cholelithiasis merges cholecystitis case 100 example.After 2 courses for the treatment of, 48 examples of fully recovering altogether, effective 27 examples, effective 15 examples, invalid 10 examples.Cure rate of the present invention is 48%, and obvious effective rate is 27%, and effective percentage is 15%, and total effective rate is 90%, and inefficiency is 10%.
Curative effect determinate standard is as follows:
Recovery from illness: clinical symptoms and sign disappear completely, and gallbladder color ultrasound examination is normal;
Effective: clinical symptoms and sign disappear substantially, gallbladder color ultrasound examination meets effective standard;
Effective: clinical symptoms and sign major part disappear, and gallbladder color ultrasound examination reaches effective standard;
Invalid: clinical symptoms and sign are all not improved, even increase the weight of, gallbladder color ultrasound examination is without improvement.
The above; be only the present invention's preferably detailed description of the invention; but protection scope of the present invention is not limited thereto; anyly be familiar with those skilled in the art in the technical scope that the present invention discloses; be equal to according to technical scheme of the present invention and inventive concept thereof and replace or change, all should be encompassed within protection scope of the present invention.
Claims (4)
1. a Chinese medicine composition for anti-inflammatory and choleretic, is characterized in that, its raw material comprises by weight: Poria 29-31 part, Rhizoma Atractylodis Macrocephalae 9-11 part, Radix Angelicae Sinensis 14-16 part, Ramulus Et Folium Picrasmae 14-16 part, Radix Paeoniae Alba 9-11 part, Herba Taraxaci 14-16 part, Radix Bupleuri 14-16 part, Pogonatum microstomum (schwaegr) Brid 9-11 part, Corydalis curviflora Maxim 4-6 part, Rhizoma Zingiberis Recens 9-11 part, Radix Glycyrrhizae 14-16 part.
2. the Chinese medicine composition of anti-inflammatory and choleretic according to claims 1, is characterized in that, the weight ratio of the Rhizoma Atractylodis Macrocephalae, Radix Angelicae Sinensis, Ramulus Et Folium Picrasmae and the Radix Paeoniae Alba is 9.7-10.8:14.2-15.6:14.4-15.7:9.5-10.1.
3. the Chinese medicine composition of anti-inflammatory and choleretic according to claims 1 or 2, it is characterized in that, its raw material comprises by weight: Poria 29.3-30.5 part, Rhizoma Atractylodis Macrocephalae 9.7-10.8 part, Radix Angelicae Sinensis 14.2-15.6 part, Ramulus Et Folium Picrasmae 14.4-15.7 part, Radix Paeoniae Alba 9.5-10.1 part, Herba Taraxaci 14.1-15.2 part, Radix Bupleuri 14.6-15.3 part, Pogonatum microstomum (schwaegr) Brid 9.9-10.2 part, Corydalis curviflora Maxim 4.7-5.2 part, Rhizoma Zingiberis Recens 9.2-10.8 part, Radix Glycyrrhizae 14.5-15.5 part.
4. the Chinese medicine composition of anti-inflammatory and choleretic according to any one of claims 1-3, it is characterized in that, its raw material comprises by weight: 30 parts, Poria, the Rhizoma Atractylodis Macrocephalae 10 parts, Radix Angelicae Sinensis 15 parts, Ramulus Et Folium Picrasmae 15 parts, the Radix Paeoniae Alba 10 parts, Herba Taraxaci 15 parts, Radix Bupleuri 15 parts, Pogonatum microstomum (schwaegr) Brid 10 parts, Corydalis curviflora Maxim 5 parts, 10 parts, Rhizoma Zingiberis Recens, 15 parts, Radix Glycyrrhizae.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410609337.2A CN104740559A (en) | 2014-10-31 | 2014-10-31 | Traditional Chinese medicine composition for diminishing inflammation and benefiting gallbladder |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410609337.2A CN104740559A (en) | 2014-10-31 | 2014-10-31 | Traditional Chinese medicine composition for diminishing inflammation and benefiting gallbladder |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104740559A true CN104740559A (en) | 2015-07-01 |
Family
ID=53581179
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410609337.2A Pending CN104740559A (en) | 2014-10-31 | 2014-10-31 | Traditional Chinese medicine composition for diminishing inflammation and benefiting gallbladder |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104740559A (en) |
-
2014
- 2014-10-31 CN CN201410609337.2A patent/CN104740559A/en active Pending
Non-Patent Citations (2)
Title |
---|
全远林等: "《中国肝胆病秘方全书》", 31 March 2003, 北京科学技术文献出版社 * |
董秀文等: "《当代心脑肾肝胆病医方集成 》", 30 September 2002, 中国医药科技出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104042802A (en) | Traditional Chinese medicine composition capable of treating fatty liver | |
CN103007113A (en) | Traditional Chinese medicinal composition for treating phlebitis and method for preparing same | |
CN105596858A (en) | Traditional Chinese medicine composition for treating yin-deficiency night sweat and preparation method thereof | |
CN104758524A (en) | Traditional Chinese medicinal composition for treating hepatic hemangioma with symptoms of phlegm dampness and retention | |
CN105796949A (en) | Decoction medicine for treating ulcer and preparation method thereof | |
CN104740558A (en) | Traditional Chinese medicine composition for treating gallstones with cholecystitis | |
CN104740559A (en) | Traditional Chinese medicine composition for diminishing inflammation and benefiting gallbladder | |
CN105031087A (en) | Medical wine with effects of dispelling wind and removing dampness and manufacturing method of medical wine | |
CN101085281A (en) | Traditional Chinese medicine for curing chronic nephritis | |
CN110193076A (en) | A kind of Chinese medicine composition and preparation for treating hypertension, hyperlipidemia, high blood viscosity | |
CN103784736A (en) | Medicine composition for treating pregnancy toxaemia of equus animals | |
CN103816238A (en) | Traditional Chinese medicine for treating goiter | |
CN104547875A (en) | Traditional Chinese medicine for treating arteries and veins stasis type chest stuffiness and pain | |
CN103536857B (en) | Traditional Chinese medicine for treating flaccid paralysis | |
CN105381410A (en) | Traditional Chinese medicinal preparation for treating hepatitis | |
CN101112436A (en) | Chinese medicine preparation for treating bacchia | |
CN105688074A (en) | Decoction medicine for treating hypogastric pain and preparation method of decoction medicine | |
CN106361881A (en) | Decoction medicament for treating scrotal eczema and preparation method of decoction medicament | |
CN105770760A (en) | Preparation for treating gastric ulcer and preparation method thereof | |
CN105497698A (en) | Neurodermatitis treatment drug for neurosurgery center | |
CN105641293A (en) | Traditional Chinese medicine composition treating pain in lateral lower abdomen and preparing method thereof | |
CN104435922A (en) | Traditional Chinese medicine composition for treating arteriosclerosis | |
CN104971240A (en) | Traditional Chinese medicinal composition for treating liver fire invading stomach type chronic gastritis | |
CN105169277A (en) | Fructus gardeniae oral liquid capable of protecting liver and benefiting gallbladder and preparation method thereof | |
CN105106469A (en) | Traditional Chinese medicine composition for mainly treating ovarian cancer and preparation method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150701 |